Seeking Alpha
  • TruffelPig
    EXEL being whipped on secondary even though FDA review for MTC drug on Nov. 17 likely great!
    8/6/12
    Reply (7)
    • lewwillis: Thx for the tip, TP
      8/6/12
    • Dr. Kris: Secondary offering is for 20M shares, a 13% dilution.
      8/6/12
    • TruffelPig: Significant, but the FDA thing ways more imo. The drop in share price today is about 12%.
      8/6/12
    • TruffelPig: I bought my shares back which I sold for 6.4 recently.
      8/6/12
    • kevin1533: thank you truffel. followed u in :D
      8/6/12
    • TruffelPig: Hehehe, don't blame me if it doesn't work out. However, I think this will be a winner.
      8/6/12
    • kevin1533: Haha ive been following this for a while. was waiting for an entry point
      8/6/12